Management of Perioperative Iron Deficiency in Cardiac Surgery: A Modified RAND Delphi Study.


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
01 2022
Historique:
received: 04 05 2020
revised: 29 10 2020
accepted: 10 11 2020
pubmed: 22 12 2020
medline: 21 1 2022
entrez: 21 12 2020
Statut: ppublish

Résumé

Over the last decade, preoperative anemia has become recognized as a clinical condition in need of management. Although the etiology of preoperative anemia can be multifactorial, two thirds of anemic elective surgical patients have iron deficiency anemia. At the same time, one third of nonanemic elective surgical patients are also iron deficient. Modified RAND Delphi methodology was used to identify areas of consensus among an expert panel regarding the management of iron deficiency in patients undergoing cardiac surgery. A list of statements was sent to panel members to respond to using a five-point Likert scale. All panel members subsequently attended a face-to-face meeting. The initial survey was presented and discussed, and panel members responded to each statement on the Likert scale again. Based on the second survey, the panel came to a consensus on recommendations. The panel recommended all patients undergoing cardiac surgery be evaluated for iron deficiency, whether or not anemia is present. Evaluation should include iron studies and reticulocyte hemoglobin content. If iron deficiency is present, with or without anemia, patients should receive parenteral iron. Erythropoietin-stimulating agents may be appropriate for some patients. Consensus of an expert panel resulted in a standardized approach to diagnosing and managing iron deficiency in patients undergoing cardiac surgery.

Sections du résumé

BACKGROUND
Over the last decade, preoperative anemia has become recognized as a clinical condition in need of management. Although the etiology of preoperative anemia can be multifactorial, two thirds of anemic elective surgical patients have iron deficiency anemia. At the same time, one third of nonanemic elective surgical patients are also iron deficient.
METHODS
Modified RAND Delphi methodology was used to identify areas of consensus among an expert panel regarding the management of iron deficiency in patients undergoing cardiac surgery. A list of statements was sent to panel members to respond to using a five-point Likert scale. All panel members subsequently attended a face-to-face meeting. The initial survey was presented and discussed, and panel members responded to each statement on the Likert scale again. Based on the second survey, the panel came to a consensus on recommendations.
RESULTS
The panel recommended all patients undergoing cardiac surgery be evaluated for iron deficiency, whether or not anemia is present. Evaluation should include iron studies and reticulocyte hemoglobin content. If iron deficiency is present, with or without anemia, patients should receive parenteral iron. Erythropoietin-stimulating agents may be appropriate for some patients.
CONCLUSIONS
Consensus of an expert panel resulted in a standardized approach to diagnosing and managing iron deficiency in patients undergoing cardiac surgery.

Identifiants

pubmed: 33345781
pii: S0003-4975(20)32128-7
doi: 10.1016/j.athoracsur.2020.11.031
pii:
doi:

Types de publication

Consensus Development Conference Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

316-323

Informations de copyright

Copyright © 2022 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Auteurs

Howard L Corwin (HL)

Critical Care Medicine, Geisinger Health System, Danville, Pennsylvania. Electronic address: howard.l.corwin@gmail.com.

Aryeh Shander (A)

Department of Anesthesiology and Critical Care Medicine, Englewood Health, TeamHealth, Englewood, New Jersey.

Bruce Speiss (B)

Department of Anesthesiology, University of Florida College of Medicine, Gainesville, Florida.

Manuel Muñoz (M)

Department of Surgical Specialties, Biochemistry and Immunology, University of Malaga School of Medicine, Malaga, Spain.

David Faraoni (D)

Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario, Canada.

Domenico Calcaterra (D)

Department of Cardiothoracic Surgery, Bethesda Heart Hospital, Baptist South Florida, Boynton Beach, Florida.

Ian Welsby (I)

Department of Anesthesiology and Critical Care, Duke University School of Medicine, Durham, North Carolina.

Sherri Ozawa (S)

Patient Blood Management, Englewood Hospital and Medical Center, Englewood, New Jersey.

Adam Arnofsky (A)

Cardiothoracic Surgery, Englewood Hospital and Medical Center, Englewood, New Jersey.

Richard S Goldweit (RS)

Interventional Cardiology, Englewood Hospital and Medical Center, Englewood, New Jersey.

Pierre Tibi (P)

Department of Cardiothoracic and Vascular Diseases, Yavapai Regional Medical Center, Prescott, Arizona.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH